UK hospitals urged to embrace intensity-modulated radiotherapy
This article was originally published in Clinica
Cancer Research UK (CRUK) is calling on hospitals to replace conventional radiotherapy with intensity-modulated radiotherapy (IMRT) as the standard form of treatment of cancers of the head and neck. Citing the results of research presented today at the National Cancer Research Institute (NCRI) Conference, in Birmingham, it highlighted the "more accurate targeting [by IMRT] of effective radiotherapy doses to the tumour, while reducing damage to healthy organs".
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.